Press "Enter" to skip to content

New patent expiration for Novartis drug AMTURNIDE

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Novartis drug AMTURNIDE

Annual Drug Patent Expirations for AMTURNIDE
Annual Drug Patent Expirations for AMTURNIDE

Amturnide is a drug marketed by Novartis and is included in one NDA. There are two patents protecting this drug.

This drug has one hundred and thirteen patent family members in thirty-one countries.

The generic ingredient in AMTURNIDE is aliskiren hemifumarate; amlodipine besylate; hydrochlorothiazide. Additional details are available on the aliskiren hemifumarate; amlodipine besylate; hydrochlorothiazide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for Novartis drug AMTURNIDE
    DrugPatentWatch - Make Better Decisions